.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Chloroquine phosphate - Generic Drug Details

« Back to Dashboard
Chloroquine phosphate is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Teva, Ipca Labs Ltd, Natco Pharma Ltd, Impax Labs, Md Pharm, Watson Labs, Hikma Pharms Llc, and Purepac Pharm, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for chloroquine phosphate. Eight suppliers are listed for this compound.

Summary for Generic Name: chloroquine phosphate

Tradenames:3
Patents:0
Applicants:9
NDAs:14
Drug Master File Entries: see list18
Suppliers / Packaging: see list8
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for Ingredient: chloroquine phosphate

Drug ClassAntimalarial

Clinical Trials for: chloroquine phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm
CHLOROQUINE PHOSPHATE
chloroquine phosphate
TABLET;ORAL080886-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Natco Pharma Ltd
CHLOROQUINE PHOSPHATE
chloroquine phosphate
TABLET;ORAL091621-001Jan 21, 2011RXNo<disabled><disabled>
Sanofi Aventis Us
ARALEN
chloroquine phosphate
TABLET;ORAL006002-001Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc